Login / Signup

Moving beyond traditional clinical trial endpoints: patient-reported outcomes illuminate the patient experience of novel AML therapies.

Thomas William LeBlanc
Published in: Leukemia & lymphoma (2023)
Keyphrases
  • patient reported outcomes
  • clinical trial
  • acute myeloid leukemia
  • phase ii
  • open label
  • double blind
  • allogeneic hematopoietic stem cell transplantation
  • study protocol
  • phase iii
  • randomized controlled trial